Who
David H. Deming
Director
Company insider
Files Form 4 as: Director, Phio Pharmaceuticals; Director, Better For You Wellness; Director, Sorrento Therapeutics; Director, Albany Molecular Research.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 4 Jun 2015
- Last trade
- 5 Feb 2026
- Last filed
- 6 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —23,800 at $0.00 | filing |
| 5 Feb 2026filed 6 Feb 2026 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —23,800 at $0.00 | filing |
| 11 Sep 2025filed 15 Sep 2025 | PHIO Phio PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 28 Feb 2024filed 6 Mar 2024 | Better For You Wellness | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 18 Jul 2023filed 6 Mar 2024 | Better For You Wellness | SEC FORM 4 Code A | —5,270,271 at $0.00 | filing |
| 2 Jun 2023filed 12 Jun 2023 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 29 Mar 2023filed 31 Mar 2023 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Dec 2022filed 28 Mar 2023 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Sep 2022filed 1 Sep 2022 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 12 Jul 2022filed 13 Jul 2022 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 12 Apr 2022filed 13 Apr 2022 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 3 Jan 2022filed 5 Jan 2022 | Better For You Wellness | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 14 Dec 2021filed 20 Dec 2021 | Better For You Wellness | SEC FORM 4 Code A | $48K403,747 at $0.12 | filing |
| 15 Sep 2017filed 18 Sep 2017 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 15 Sep 2017filed 15 Sep 2017 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 31 Aug 2017filed 5 Sep 2017 | Albany Molecular Research | SEC FORM 4 Code D | $149K6,838 at $21.75 | filing |
| 31 Aug 2017filed 5 Sep 2017 | Albany Molecular Researchoption or derivative | SEC FORM 4 Code D | $31K9,358 at $3.34 | filing |
| 8 Feb 2017filed 10 Feb 2017 | Albany Molecular Research | SEC FORM 4 Code A | —3,802 at $0.00 | filing |
| 8 Feb 2017filed 10 Feb 2017 | Albany Molecular Researchoption or derivative | SEC FORM 4 Code A | —9,358 at $0.00 | filing |
| 11 Jul 2016filed 12 Jul 2016 | Sorrento Therapeuticsoption or derivative | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.